姜黄素
乳腺癌
化学
生物利用度
癌症
药理学
药品
组合化学
内科学
生物化学
医学
作者
Ying Yin,Yan Tan,Xueni Wei,Xiaoshun Li,Hongfei Chen,Zehua Yang,Guotao Tang,Yongxia Xu,Pengbing Mi,Xing Zheng
标识
DOI:10.1002/cbdv.202200485
摘要
Curcumin is a potential plant-derived drug for the treatment of breast cancer. Poor solubility and bioavailability are the main factors that limit its clinical application. Various structural modification strategies have been developed to improve the anti-breast cancer activity of curcumin. This review focuses on the difference of modification sites and heterocyclic/non-heterocyclic modifications to systematically summarize curcumin derivatives with better anti-breast cancer activity.
科研通智能强力驱动
Strongly Powered by AbleSci AI